SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Pluristem Therapeutics, Inc. (PSTI)

PSTI RSS Feed
Add PSTI Price Alert      Hide Sticky   Hide Intro
Moderator: n3m3sis
Search This Board: 
Last Post: 11/18/2017 12:19:46 AM - Followers: 146 - Board type: Free - Posts Today: 1

 

Pluristem Therapeutics Inc. (Nasdaq: PSTI) 

 

 

http://www.pluristem.com/

 

 


 

Company Information:

Matam Advanced Technology Park
Building #20
Haifa 31905,  Israel

Tel :  +972-74-710-7171
Fax : +972-74-710-7172
E-Mail: info@pluristem.com

 

CIK:  0001158780

 

Pluristem Therapeutics Inc. (NASDAQ: PSTI; DAX: PJT) is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases.

Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product.

The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. 

 

Management: 

http://www.pluristem.com/index.php/about2/management.html
 

Clinical Program: 

http://www.pluristem.com/index.php/clinic-program.html


Recent News and Press:

http://www.pluristem.com/index.php/press-room.html

http://finance.yahoo.com/q/h?s=PSTI+Headlines

http://seekingalpha.com/symbol/PSTI

 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001158780&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany


 

 

 

Transfer Agent:

Nevada Agency and Transfer Company
50 W. Liberty St.
Suite 880
Reno, NV 89501

 

Investor Relations:   U.S.A.
Karine Kleinhaus, M.D., M.P.H.
Divisional VP, North-America
karinek@pluristem.com


 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

SureTrader
Interactive Brokers Advertisement
PSTI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PSTI News: Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights 11/14/2017 07:00:00 AM
PSTI News: Quarterly Report (10-q) 11/07/2017 04:09:24 PM
PSTI News: Pluristem Enters into Agreement with Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chron... 11/06/2017 07:00:00 AM
PSTI News: Following Approval of Israel’s Ministry of Health, Pluristem Extends its Trial of PLX-R18 to Treat Insufficient Hematopoiet... 10/26/2017 07:00:00 AM
PSTI News: Pluristem Expands its Reach in the Treatment of Impaired Hematopoietic Systems with a European Patent Covering PLX-R18 in Che... 10/23/2017 07:00:00 AM
PostSubject
#8104  Sticky Note All PSTI Board Posters - For Clarification. n3m3sis 11/10/17 08:11:05 AM
#8387   Like any compensated cheerleader zzaatt 11/18/17 12:19:46 AM
#8386   I seriously doubt that.....and please...define...."a short time". EichKing 11/17/17 10:41:31 PM
#8385   First, I haven't used the word vomit or EichKing 11/17/17 10:36:39 PM
#8384   You spew out of the both sides of zzaatt 11/17/17 09:27:29 PM
#8383   Let's be honest....most stem cell therapies are dubious zzaatt 11/17/17 09:15:01 PM
#8382   No controller sorry. Makes zero sense any way Scott999 11/17/17 07:54:52 PM
#8381   I happen to agree there is manipulation going EichKing 11/17/17 07:34:16 PM
#8380   How Do You Know They Didn't ? Maybe FDApproved 11/17/17 07:17:23 PM
#8379   Your words: EichKing 11/17/17 07:02:57 PM
#8378   Nobody Ever Said They Had Done A Licensing FDApproved 11/17/17 06:51:32 PM
#8377   BS....if PSTI found out someone was manipulating the EichKing 11/17/17 06:43:07 PM
#8376   I Agree 100 Percent Zzaatt....I Have Often Thought FDApproved 11/17/17 06:33:16 PM
#8375   Section 13(d) of the 1934 Act and Regulation EichKing 11/17/17 06:20:29 PM
#8374   I Have Speculated For Quite Some Time That zzaatt 11/17/17 06:13:53 PM
#8373   Hello jp7204, FDA is right, it is just HappyBee 11/17/17 05:36:59 PM
#8372   I Have Speculated For Quite Some Time That FDApproved 11/17/17 04:59:23 PM
#8371   I agree this thing wanted to run today thesaud 11/17/17 04:22:52 PM
#8370   It's A Figure Of Speech..She Means She Does FDApproved 11/17/17 03:21:19 PM
#8369   What do you mean I'm afraid jp7204 11/17/17 03:15:47 PM
#8368   You are implying again I am lying, while EichKing 11/17/17 02:59:11 PM
#8367  Restored Apologies, jp7204, I completely forgot to respond to HappyBee 11/17/17 02:35:17 PM
#8366   This makes perfect sense, Z., thank you. HappyBee 11/17/17 02:31:12 PM
#8365   Midas, one other thought to keep in mind....on EichKing 11/17/17 02:14:15 PM
#8364   Does anybody seriously think that any poster here zzaatt 11/17/17 02:06:46 PM
#8363   It's Quite Obvious The " Controller " Does FDApproved 11/17/17 01:50:11 PM
#8362   Hello n3m3sis, many thanks for highlighting this with HappyBee 11/17/17 01:21:45 PM
#8361   So It Looks Like The DoD Did Retain FDApproved 11/17/17 01:21:16 PM
#8360   Hello Z. HappyBee 11/17/17 01:18:59 PM
#8359   That article is not accurate. Here is the n3m3sis 11/17/17 01:01:13 PM
#8358   Unfortunately, a hostile takeover ends up on the zzaatt 11/17/17 12:16:53 PM
#8357   DoD Is Watching & Waiting ! This Is FDApproved 11/17/17 12:08:03 PM
#8356   I would think that to be the case, D theG 11/17/17 10:26:51 AM
#8355   Unfortunately, a hostile takeover ends up on the EichKing 11/17/17 10:25:52 AM
#8354   Definitely!!!!! Others would follow almost immediately. South Korea, Japan, n3m3sis 11/17/17 10:20:59 AM
#8353   Here's to hoping! That one signed deal would D theG 11/17/17 10:19:17 AM
#8352   True, given that they can approve PLX R18 n3m3sis 11/17/17 10:11:15 AM
#8351   Agreed, I don't think there is any question D theG 11/17/17 09:56:06 AM
#8350   We ALL Know President Trump Will Sign The FDApproved 11/17/17 09:47:58 AM
#8349   Great Work..N3m3sis..It Also Looks Likely The DoD Wants FDApproved 11/17/17 09:26:55 AM
#8348   For a recap of what it means if n3m3sis 11/17/17 09:14:59 AM
#8347   Thanks n3m! Good find! I know sometimes they D theG 11/17/17 09:00:43 AM
#8346   It is in there!!!! n3m3sis 11/17/17 08:57:12 AM
#8344   HI D theG n3m3sis 11/17/17 08:32:28 AM
#8343   Great News! FDA. n3m3sis 11/17/17 08:31:04 AM
#8342   FDA, Did the final bill contain the section D theG 11/17/17 08:27:27 AM
#8341   1.63 In Pre-Market ! FDApproved 11/17/17 08:21:58 AM
#8340   Stock-Piling Deal Coming.... Merry Christmas And Happy Hanukah FDApproved 11/17/17 07:35:15 AM
#8339   Breaking News !... The Bill Passed Awaiting Presidents FDApproved 11/17/17 07:12:17 AM
#8338   Hostile takeover. I'd take that midastouch017 11/17/17 05:42:12 AM
#8337   I have done the same Midas. Luckily for Scott999 11/17/17 05:15:16 AM
PostSubject